№ lp_2_3_30265
File format: docx
Character count: 28022
File size: 137 KB
The document summarizes discussions about eDRX cycles configurations for RRC_IDLE and RRC_INACTIVE, including company feedback and proposals for future configurations.
Year:
2021
Region / city:
Not specified
Topic:
eDRX cycles
Document Type:
Draft
Organization / Institution:
3GPP TSG-RAN WG2
Author:
vivo, Qualcomm, OPPO, Huawei, HiSilicon, Xiaomi, Samsung, LGE
Target audience:
Members of the 3GPP working groups
Period of validity:
August 2021
Approval Date:
Not specified
Date of changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / city:
Global
Topic:
eDRX cycle length for RedCap devices
Document type:
Technical discussion summary
Organization:
3GPP TSG-RAN WG2
Author:
Ericsson
Target audience:
Telecommunications companies and network engineers
Period of validity:
N/A
Approval date:
N/A
Amendment date:
N/A
Organization:
3GPP TSG-RAN WG4
Meeting:
RAN4#101-bis-e
Document Number:
R4-22XXXX
Meeting Type:
Electronic Meeting
Date:
January 17–25, 2022
Agenda Items:
6.20.3.2; 6.20.3.3
Source:
vivo
Subject:
eDRX and RRM measurement relaxations requirements for NR RedCap UE
Document For:
Approval
Technology:
NR (New Radio)
Frequency Ranges:
FR1, FR2
Topic:
Extended DRX enhancements and RRM measurement requirements
Status:
Agreements and tentative agreements recorded
Year:
2021
Region / City:
Electronic meeting
Topic:
eDRX configuration
Document Type:
Meeting Summary
Organization:
Intel Corporation
Author:
Intel Corporation
Target Audience:
3GPP RAN2 working group members
Period of validity:
2021-04-12 to 2021-04-20
Approval Date:
2021-04-16
Modification Date:
N/A
Year:
2022
Region / City:
Global (3GPP)
Topic:
RedCap eDRX support and related protocol agreements
Document Type:
Meeting report / technical discussion summary
Organization:
3GPP TSG-RAN3
Author:
Ericsson (Moderator)
Participants:
Ericsson, Nokia, Huawei, Qualcomm, Samsung, CATT, CMCC, ZTE
Target Audience:
3GPP working group members
Period Covered:
17–26 January 2022
Agenda Item:
11.3
References:
R3-220193, R3-220194, R3-220233, R3-220281, R3-220282, R3-220449, R3-220450, R3-220451, R3-220461, R3-220463, R3-220566, R3-220724, R3-220861, R3-220893, R3-220894
Discussion Topics:
NR Paging eDRX Information, F1/Xn/NG interfaces, RedCap UE indications, IE naming conventions, procedure text agreements, Rel-17 updates
Decisions:
No final consensus in some topics; proposals and preferences noted; moderator conclusions TBD
Year:
2021
Region / City:
Online
Topic:
eDRX cycles for Idle and Inactive
Document Type:
Meeting Summary
Organization:
CATT
Author:
Pierre Bertrand
Target Audience:
Companies involved in the discussion
Period of Validity:
January 2021
Approval Date:
January 2021
Amendment Date:
February 2021
Year:
2022
Region / City:
Not specified
Topic:
Bone health, flavonoids, sea buckthorn
Document Type:
Research Table
Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers in pharmacology, bone health, and phytochemistry
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Contextual description
Year:
2022
Region / city:
Online
Topic:
SL LBT failure detection and recovery procedure
Document Type:
Draft
Organization / institution:
3GPP TSG-RAN WG2
Author:
vivo (Rapporteur)
Target audience:
Industry professionals, telecommunications companies
Effective period:
October 2022
Approval date:
Not specified
Date of changes:
Not specified
Title:
The ARRIVE reporting checklist
Related guideline:
ARRIVE guidelines 2.0
Subject:
Reporting standards for in vivo animal research
Document type:
Reporting checklist
Scope:
Articles describing in vivo animal experiments
Sections:
Essential 10; Recommended Set
Items:
21 main items with sub-items
Key topics:
Study design; Sample size; Inclusion and exclusion criteria; Randomisation; Blinding/Masking; Outcome measures; Statistical methods; Experimental animals; Experimental procedures; Results; Ethical statement; Housing and husbandry; Animal care and monitoring; Interpretation; Generalisability; Protocol registration; Data access; Declaration of interests
Cited work 1:
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research, PLOS Biology, 2020 Jul;18(7):e3000410
Cited work 2:
The ARRIVE reporting checklist, The EQUATOR Network reporting guideline platform, The UK EQUATOR Centre, 2025
Authors cited:
Sert NP; Hurst V; Ahluwalia A; Alam S; Avey MT; Baker M; et al.
Intended users:
Authors preparing manuscripts on animal research
Purpose:
To document adherence to reporting standards in animal experiments
Year:
2020
Region / City:
e-Meeting, May 25th – June 5th
Theme:
Enhanced Configured Grant Transmission for URLLC
Document Type:
Email Discussion
Organization / Institution:
3GPP TSG RAN WG1
Author:
Chairman
Target Audience:
Members of 3GPP TSG RAN WG1
Period of Validity:
Until May 29th, 2020
Date of Approval:
May 25th, 2020
Date of Changes:
Not specified
Year:
2026
Region / City:
Seoul, Korea
Topic:
Medical Research, Genome Editing, Ophthalmology
Document Type:
Research Article
Organization / Institution:
Seoul National University Hospital, Seoul National University College of Medicine
Author:
Jeong Hun Kim
Target Audience:
Researchers, Clinicians, Medical Professionals
Period of Effect:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual Description:
Research article presenting recent experimental results and clinical trial preparations regarding in vivo genome editing for treating vision-threatening retinopathies, such as AMD, DR, and ROP.
In Vivo Anti-Inflammatory and Anti-Nociceptive Activities of Aerial Part Extracts of Zehneria scabra
Year:
Not specified
Journal:
International Journal of Pharmacy and Industrial Research
ISSN (Print):
2231–3648
ISSN (Online):
2231–3656
Article Type:
Research Article
Author:
Baye Akele
Affiliation:
University of Gondar, College of Medicine and Health
Address:
P.O Box 196, Gondar, Ethiopia
Email:
[email protected]
Study Subject:
Zehneria scabra (Cucurbitaceous family)
Study Design:
In vivo experimental study
Experimental Models:
Acetic acid–induced writhing test; Carrageenan-induced inflammation
Extraction Method:
80% methanol extraction by maceration
Test Organisms:
Swiss albino mice (18–25 g)
Region of Plant Collection:
North east Ethiopia
Plant Identification Repository:
National Herbarium, Botanic Laboratory, Addis Ababa University, Ethiopia
Keywords:
Antinociceptive, Anti-inflammatory, Zehneria scabra, Maceration
Year:
2023
Region / city:
N/A
Subject:
Immunology, Cell Biology
Document type:
Supplementary Table
Organization:
N/A
Author:
N/A
Target audience:
Researchers, scientists in immunology and cell biology
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
2014
Region / City:
Pittsburgh, PA, USA
Subject:
Government procurement of imaging and laboratory equipment
Document Type:
Contract amendment / solicitation modification
Issuing Agency:
U.S. Department of Veterans Affairs, Veterans Health Administration, Service Area Office East
Contractor:
Bruker Biospin Corp.
Contracting Officer:
Travis Gibbons
Effective Date:
25-Jul-2014
Solicitation Number:
VA268-14-Q-0031
Amendment Number:
1
Equipment Included:
In Vivo Xtreme Imaging System, Multimodal Animal Rotation System (MARS), Anesthesia System, Bone Density Software Module
Purpose:
Correct description of line item 1 and update price schedule
Key Features:
Fluorescence and bioluminescence imaging, multi-animal anesthesia, skeletal X-ray co-localization, high-resolution camera, software upgradability, PET/SPECT imaging, multi-angle imaging without handling animals
Exempt Distribution of Carbon14 Urea Capsules for In Vivo Diagnostic Use in Humans, Effective 1/2/98
Year:
1998
Agency:
U.S. Nuclear Regulatory Commission
Document Type:
Federal Regulation / Rule
Subject:
Radioactive Drugs, Licensing Exemptions
RATS ID:
19977
Effective Date:
1/2/1998
CFR Sections:
30.21, 32.21, 32.21a
Usage Restrictions:
In vivo diagnostic use for humans only; not for research involving human subjects; not for incorporation into food, beverages, cosmetics, or other drugs
License Requirements:
Specific license required for commercial distribution, manufacture, or research use
Labeling Requirements:
Must indicate radioisotope, physical/chemical form, activity, and usage restrictions
Year:
2016
Institution:
University of Wisconsin–Madison
Document type:
Request for Bid / Contract Solicitation
Contract number:
17-5725-R1
Issue date:
8/17/16
Due date:
8/31/16, 2:00 PM CDT
Agent:
Janet Bresnahan
Scope:
In Vivo Drug Discovery Pharmacology Assays, Pharmacokinetics and Dose Tolerability in Rodents
Contract duration:
One year from award, automatically renewable for two additional one-year terms
Bid submission requirements:
Hard copy, CD/DVD/Flash drive, signatures required
Applicable rules:
Federal procurement rules, University standard terms and conditions
Sections included:
Submittal Instructions, General Information, RFB Process Instructions, Bidder Qualifications, Performance and Contract Requirements, Attachments A–H
Audience:
Potential vendors and contractors for pharmacology research services
Contextual description:
Official bid solicitation detailing requirements, procedures, and conditions for vendors to provide in vivo pharmacology testing services at the University of Wisconsin–Madison under a specified contract.
Year:
2016
Region / City:
Shanghai, China; Shenzhen, China; Suzhou, China; Helsinki, Finland; Turku, Finland
Subject:
Tissue engineering, vascularization, skin flap regeneration
Document Type:
Peer-reviewed research article
Institution / Organization:
Shanghai Ninth People’s Hospital, Xi’an Jiaotong University, Shenzhen Institutes of Advanced Technology, University of Helsinki, Soochow University, Åbo Akademi University
Authors:
Xiaoming Sun, Qi Lang, Hongbo Zhang, Liying Cheng, Ying Zhang, Guoqing Pan, Xin Zhao, Huilin Yang, Yuguang Zhang, Hélder A. Santos, Wenguo Cui
Target Audience:
Researchers in biomedical engineering and regenerative medicine
Methodology:
Electrospinning of photocrosslinkable gelatin methacryloyl (GelMA) hydrogels
Key Findings:
Enhanced endothelial cell adhesion, proliferation, migration, tubulogenesis, and increased skin flap survival in rat models
Publication DOI:
10.1002/adfm.201604617
Access:
Non-commercial use under Wiley Terms and Conditions
Year:
2023
Region / City:
Not specified
Topic:
Fetal cardiac function, hypoxic pregnancy, echocardiography
Document type:
Scientific research article
Institution:
Not specified
Authors:
Patey, KL Botting, Y Niu, L Zhang, J Ma, SG Ford, W Tong, CM Coutinho, B Thilaganathan, DA Giussani
Target audience:
Researchers, clinicians, scientists in the field of prenatal health, cardiology, and animal models
Period of validity:
Not specified
Approval date:
Not specified
Date of revisions:
Not specified